research Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'
Hair loss link to COVID-19 severity likely due to other factors.
Search
for
Sort by
Research
570-600 / 714 results 
research Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19
Women with high androgen levels may have more severe COVID-19 symptoms.
research Acute Telogen Effluvium: A Sequela of COVID-19 Infection
COVID-19 can cause temporary hair loss.
research Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 Participants
COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.
research The Role of Androgens in Androgenetic Alopecia Associated with the Severity of COVID-19
Androgens play a key role in causing alopecia by changing the hair growth cycle.
research Androgenetic Alopecia as a Complication of SARS-CoV-2 Infection
People with androgenetic alopecia may have a higher risk of severe COVID-19.
research Reply to Letter to the Editor: A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19'
Balding might help identify men at higher risk for severe COVID-19, but more research is needed.
research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.
research The Association of Hair Loss and Coronavirus Infection COVID-19 – Facts and Hypotheses
COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.
research The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies
Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.
research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19
Cepharanthine could be a strong antiviral against COVID-19.
research The Role of SARS-CoV-2 Infection and Its Vaccines in Various Types of Hair Loss
COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.
research Increased Risk of Chronic Fatigue and Hair Loss Following COVID-19 in Individuals with Hypohidrotic Ectodermal Dysplasia
People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.
research Cutaneous Manifestations of COVID-19
Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.
research Capillary Diseases in Patients Who Had COVID-19
COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.
research COVID-19 Infection: Impact on Hair
COVID-19 may cause increased and quicker hair loss compared to other infections.
research Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.
research SARS-CoV-2-Induced Host Metabolic Reprogramming: Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae
Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.
research The Effect of Low-Level Laser Therapy on Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cells
Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.
research Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects
COVID-19 can cause a temporary hair loss condition.
research Identifying Long-Term Effects of SARS-CoV-2 and Their Association with Social Determinants of Health in a Cohort of Over One Million COVID-19 Survivors
The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.
research Genetic and Hormonal Influence on SARS-CoV-2 Infection Susceptibility
Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.
research Discovery of Clinically Approved Drugs Capable of Inhibiting SARS-CoV-2 In Vitro Infection Using a Phenotypic Screening Strategy and Network-Analysis to Predict Their Potential to Treat COVID-19
Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.
research Intra-Host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations
Some early COVID-19 mutations in patients predicted future common virus mutations.
research A Prospective Cross-Sectional Study on Post COVID-19 Hair Loss at a Tertiary Care Hospital
Many patients experienced severe hair loss after COVID-19, especially older adults and women.
research In Silico Screening of Moroccan Medicinal Plants with the Ability to Directly Inhibit the Novel Coronavirus, SARS-CoV-2
Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.
research New Product Introductions: Finasteride/Tadalafil (New Combination); Sutimlimab; Human SARS-CoV-2 Recombinant Nanoparticle Vaccine, Adjuvanted with AS03; Bupropion Hydrochloride/Dextromethorphan Hydrobromide (New Combination)
research Medical Education and Care in Dermatology During the SARS-CoV-2 Pandemic: Challenges and Opportunities
The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.
research Low Neutralizing Antibody Titers After Asymptomatic or Non-Severe SARS-CoV-2 Infection Over a 6-Month Assessment Period
People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.
research Persistence of Long-COVID Symptoms in a Heterogeneous Prospective Cohort
Long-COVID symptoms can last more than a year and change over time.